Graham Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $375K | Buy |
523,378
+319,840
| +157% | +$229K | 0.01% | 881 |
|
|
2025
Q1 | $299K | Buy |
203,538
+140,506
| +223% | +$207K | 0.01% | 966 |
|
|
2024
Q4 | $279K | Sell |
63,032
-44,938
| -42% | -$199K | ﹤0.01% | 934 |
|
|
2024
Q3 | $445K | Buy |
+107,970
| New | +$445K | 0.01% | 635 |
|
|
2024
Q2 | – | Sell |
-13,537
| Closed | -$118K | – | 1163 |
|
|
2024
Q1 | $118K | Buy |
+13,537
| New | +$118K | ﹤0.01% | 935 |
|
|
2022
Q4 | – | Sell |
-18,177
| Closed | -$188K | – | 1162 |
|
|
2022
Q3 | $188K | Sell |
18,177
-74,900
| -80% | -$775K | 0.01% | 986 |
|
|
2022
Q2 | $1.07M | Buy |
+93,077
| New | +$1.07M | 0.04% | 408 |
|
|
2022
Q1 | – | Sell |
-24,724
| Closed | -$288K | – | 940 |
|
|
2021
Q4 | $288K | Buy |
+24,724
| New | +$288K | 0.01% | 332 |
|